Tocagen On The Rocks With Phase III Brain Cancer Study Failure

 
• By Joseph Haas
  
male doctor in studio, thumbs down, showing failed, bad news - Image
Tocagen's TOCA 5 trial missed the primary, all secondary endpoints
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D